{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:57:42Z","timestamp":1761742662950},"reference-count":30,"publisher":"Japanese Circulation Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1253\/circj.69.1394","type":"journal-article","created":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T05:57:19Z","timestamp":1130219839000},"page":"1394-1400","source":"Crossref","is-referenced-by-count":6,"title":["Long-Term Effect of Spironolactone on Cardiac Structure as Assessed by Analysis of Ultrasonic Radio-Frequency Signals in Patients With Ventricular Hypertrophy"],"prefix":"10.1253","volume":"69","author":[{"given":"Nagahiro","family":"Nishikawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Mano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Umekawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Yasuhara","sequence":"additional","affiliation":[{"name":"Medical Ultrasound Engineering Department, Aloka Co Ltd"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruyuki","family":"Sonoyama","sequence":"additional","affiliation":[{"name":"Medical Ultrasound Engineering Department, Aloka Co Ltd"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimitsu","family":"Harada","sequence":"additional","affiliation":[{"name":"Medical Ultrasound Engineering Department, Aloka Co Ltd"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Masuyama","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Department of Internal Medicine, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: Fibrosis and renin- angiotensin- aldosterone system. Circulation 1991; 83: 1849-1865.","DOI":"10.1161\/01.CIR.83.6.1849"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Katayama T, Nakashima H, Takagi C, Honda Y, Suzuki S, Yano K. Predictors of mortality in patients with acute myocardial infarction and cardiogenic shock. Circ J 2005; 69: 83-88.","DOI":"10.1253\/circj.69.83"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on mortality and morbidity in patients with severe heart failure. N Engl J Med 1999; 341: 709-717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pitt B, Remme WJ, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309-1321.","DOI":"10.1056\/NEJMoa030207"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hall CS, Scott MJ, Lanza GM, Miller JG, Wickline SA. The extracellular matrix is an important source of ultrasound backscatter from myocardium. J Acoust Soc Am 2000; 107: 612-619.","DOI":"10.1121\/1.428327"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Miller JG, Perez JE, Sobel BE. Ultrasonic characterization of myocardium. Prog Cardiovasc Dis 1985; 28: 85-110.","DOI":"10.1016\/0033-0620(85)90020-9"},{"key":"7","unstructured":"7. Skorton DJ, Miller JG, Wickline S, Barzilai B, Collins S, Perez JE. Ultrasonic characterization of cardiovascular tissue. <i>In:<\/i> Marcus ML, Schelbert HR, Skorton DJ, et al, editors. Cardiac imaging. Philadelphia: WB Saunders; 1991; 538-556."},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Kozakova M, Buralli S, Palombo C, Bernini G, Moretti A, Favilla S, et al. Myocardial ultrasonic backscatter in hypertension: Relation to aldosterone and endothelin. Hypertension 2003; 41: 230-236.","DOI":"10.1161\/01.HYP.0000052542.68896.2B"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Naito J, Masuyama T, Tanouchi J, Mano T, Kondo H, Yamamoto K, et al. Analysis of transmural trend of myocardial integrated ultrasonic backscatter for the differentiation of hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension. J Am Coll Cardiol 1994; 24: 517-524.","DOI":"10.1016\/0735-1097(94)90312-3"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Maceira AM, Barba J, Varo N, Beloqui O, Diez J. Ultrasonic backscatter and serum marker of cardial fibrosis in hypertensives. Hypertension 2002; 39: 923-928.","DOI":"10.1161\/01.HYP.0000014616.48920.8F"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Naito J, Masuyama T, Mano T, Kondo H, Yamamoto K, Nagano R, et al. Ultrasonic myocardial tissue characterization in patients with cardiomyopathy: Value in noninvasive assessment of myocardial fibrosis. Am Heart J 1996; 131: 115-121.","DOI":"10.1016\/S0002-8703(96)90059-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Masuyama T, Yamamoto K, Nishikawa N, Sakata Y, Mano T, Hori M, et al. New attempt of ultrasonic tissue characterization: Decreased chaos in myocardial echo in patients with dilated cardiomyopathy. Ultrasound Med Biol 2002; 28: 93-99.","DOI":"10.1016\/S0301-5629(01)00496-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Schwarz ER, Pollick C, Dow J, Patterson M, Birnbaum Y, Kloner RA. A small animal model of non-ischemic cardiomyopathy and its evaluation by transthoracic echocardiography. Cardiovasc Res 1998; 39: 216-223.","DOI":"10.1016\/S0008-6363(98)00009-1"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, et al. Development of different phenotypes of hypertensive heart failure: Systolic versus diastolic failure in Dahl salt-sensitive rats. J Hypertens 2000; 18: 111-120.","DOI":"10.1097\/00004872-200018010-00016"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Hori M, et al. Activation of matrix metalloproteinases precedes LV remodeling in hypertensive heart failure rats: Its inhibition as a primary effect of ACE inhibitor. Circulation 2004; 109: 2143-2149.","DOI":"10.1161\/01.CIR.0000125741.88712.77"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yamamoto K, Masuyama T, Tanouchi J, Naito J, Mano T, Kondo H, et al. Intraventricular dispersion of early diastolic filling: A new marker of left ventricular diastolic dysfunction. Am Heart J 1995; 129: 291-299.","DOI":"10.1016\/0002-8703(95)90011-X"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-994.","DOI":"10.1161\/01.HYP.28.6.988"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yamamoto K, Nishimura RA, Chaliki HP, Appleton CP, Holmes DR Jr, Redfield MM. Determination of left ventricular filling pressure by Doppler echocardiography in patients with coronary artery disease: Critical role of left ventricular systolic function. J Am Coll Cardiol 1997; 30: 1819-1826.","DOI":"10.1016\/S0735-1097(97)00390-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters WL Jr, et al. A new simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981; 64: 744-753.","DOI":"10.1161\/01.CIR.64.4.744"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.","DOI":"10.1016\/0002-9149(86)90771-X"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Cuspidi C, Lonati L, Sampieri L, Valagussa L, Michev I, Leonetti G, et al. Lack of correlation between left ventricular mass and diameter of left coronary artery main trunk in hypertensive patients. Am J Hypertens 1999; 12: 1163-1168.","DOI":"10.1016\/S0895-7061(99)00130-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sierra C, Sierra A, Pare JC, Gomez-Angelats E, Coca A. Correlation between silent cerebral white matter lesions and left ventricular mass and geometry in essential hypertension. Am J Hypertens 2002; 15: 507-512.","DOI":"10.1016\/S0895-7061(02)02277-X"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Matsumoto R, Yoshiyama M, Omura T, Kim S, Nakamura Y, Izumi Y, et al. Effects of aldosterone receptor antagonist and angiotensin II type 1 receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction. Circ J 2004; 68: 376-382.","DOI":"10.1253\/circj.68.376"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: Insights from the Randomized Aldosterone Evaluation Study (RALES). Circulation 2000; 102: 2700-2706.","DOI":"10.1161\/01.CIR.102.22.2700"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Laviades C, Varo N, Fernandez J, Mayor G, Gil MJ, Monreal I, et al. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998; 98: 535-540.","DOI":"10.1161\/01.CIR.98.6.535"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26: 809-820.","DOI":"10.1006\/jmcc.1994.1098"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Harada E, Yoshimura M, Yasue H, Nakagawa O, Nakagawa M, Harada M, et al. Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes. Circulation 2001; 104: 137-139.","DOI":"10.1161\/01.CIR.104.2.137"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, et al. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 2001; 37: 1228-1233.","DOI":"10.1016\/S0735-1097(01)01116-0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Rousseau MF, Gurne O, Duprez D, van Mieghem W, Robert A, Ahn S, et al. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: Results from the RALES neurohormonal substudy. J Am Coll Cardiol 2002; 40: 1596-1601.","DOI":"10.1016\/S0735-1097(02)02382-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, et al. Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 2002; 40: 304-310.","DOI":"10.1016\/S0735-1097(02)01965-4"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/69\/11\/69_11_1394\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T03:28:02Z","timestamp":1680319682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/69\/11\/69_11_1394\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.69.1394","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}